§ Federal grant opportunity · DFOP0019410
U.S.-Africa Strategic Investment Program
Bureau of African Affairs is accepting applications for U.S.-Africa Strategic Investment Program. The deadline is May 27, 2027 and the published award range is $5M – $50M.
Key facts
- Funder
- Bureau of African Affairs
- Application deadline
- May 27, 2027
- Award range
- $5M – $50M
- Eligibility
- Public International Organizations are also eligible. Recipients must demonstrate alignment with or a commitment to advancing U.S. supply chain goals.
- Geography
- United States
- Focus areas
- Economic Development
- Opportunity number
- DFOP0019410
Program overview
The U.S.-Africa Strategic Investment Program advances America's national interests by harnessing market-based, private sector-led growth across two strategic focus areas: Critical Minerals Investment and Commercial Diplomacy Acceleration. This program seeks market-based solutions that strengthen the environment for foreign investment in sub-Saharan Africa through transparent and competitive processes, creating sustainable economic growth in two strategic focus areas. Projects must demonstrate clear, measurable benefits to one or more sub-Saharan countries, such as increased investment from high-quality U.S. and U.S.-aligned companies. Applicants are also encouraged to identify how their projects create conditions that enable U.S. commercial participation.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from Bureau of African Affairs.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before May 27, 2027, allowing time for registration and validation.
Related grant opportunities
- Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
- Antarctic Research Requiring U.S. Antarctic Program (USAP) Support for Fieldwork
- Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
- Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
- NEA Arts and Artifacts Domestic Indemnity Program 2, FY2027 (12/26)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.